These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38515708)

  • 1. EP300 regulates the SLC16A1-AS1-AS1/TCF3 axis to promote lung cancer malignancies through the Wnt signaling pathway.
    Sun Y; Sun J; Ying K; Chen J; Chen T; Tao L; Bian W; Qiu L
    Heliyon; 2024 Mar; 10(6):e27727. PubMed ID: 38515708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA LEF1-AS1/LEF1/FUT8 Axis Mediates Colorectal Cancer Progression by Regulating α1, 6-Fucosylationvia Wnt/β-Catenin Pathway.
    Qi Y; Shan Y; Li S; Huang Y; Guo Y; Huang T; Zhao X; Jia L
    Dig Dis Sci; 2022 Jun; 67(6):2182-2194. PubMed ID: 34021424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-induced lncRNA STEAP3-AS1 activates Wnt/β-catenin signaling to promote colorectal cancer progression by preventing m
    Zhou L; Jiang J; Huang Z; Jin P; Peng L; Luo M; Zhang Z; Chen Y; Xie N; Gao W; Nice EC; Li JQ; Chen HN; Huang C
    Mol Cancer; 2022 Aug; 21(1):168. PubMed ID: 35986274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNASEH1-AS1 exacerbates the progression of non-small cell lung cancer by acting as a ceRNA to regulate microRNA-516a-5p/FOXK1 and thereby activating the Wnt/β-catenin signaling pathway.
    Zhang C; Huang J; Lou K; Ouyang H
    Cancer Med; 2022 Apr; 11(7):1589-1604. PubMed ID: 35166053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA NCK1-AS1 exerts oncogenic property in gastric cancer by targeting the miR-22-3p/BCL9 axis to activate the Wnt/β-catenin signaling.
    Guan B; Ma J; Yang Z; Yu F; Yao J
    Environ Toxicol; 2021 Aug; 36(8):1640-1653. PubMed ID: 33974352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA CBR3-AS1 potentiates Wnt/β-catenin signaling to regulate lung adenocarcinoma cells proliferation, migration and invasion.
    Hou M; Wu N; Yao L
    Cancer Cell Int; 2021 Jan; 21(1):36. PubMed ID: 33422081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OPA Interacting Protein 5 Antisense RNA 1 Expedites Cell Migration and Invasion Through FOXM1/ Wnt/β-Catenin Pathway in Pancreatic Cancer.
    Shi C; Zhang H; Wang M; Tian R; Li X; Feng Y; Peng F; Qin R
    Dig Dis Sci; 2022 Mar; 67(3):915-924. PubMed ID: 33782807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGD5-AS1 facilitates glioblastoma progression by activation of Wnt/β-catenin signaling via regulating miR-129-5p/HNRNPK axis.
    Wu L; Zhu X; Song Z; Guo M; Liang J; Yan D
    Life Sci; 2020 Sep; 256():117998. PubMed ID: 32585241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway.
    Lei T; Zhu X; Zhu K; Jia F; Li S
    Cancer Biol Ther; 2019; 20(7):1007-1016. PubMed ID: 30929558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lncRNA DLX6-AS1 promoted cell proliferation, invasion, migration and epithelial-to-mesenchymal transition in bladder cancer via modulating Wnt/β-catenin signaling pathway.
    Guo J; Chen Z; Jiang H; Yu Z; Peng J; Xie J; Li Z; Wu W; Cheng Z; Xiao K
    Cancer Cell Int; 2019; 19():312. PubMed ID: 31787849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA ZEB2-AS1 contributes to the tumorigenesis of gastric cancer via activating the Wnt/β-catenin pathway.
    Wang F; Zhu W; Yang R; Xie W; Wang D
    Mol Cell Biochem; 2019 Jun; 456(1-2):73-83. PubMed ID: 30635820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. lncRNA FLVCR1-AS1 silencing inhibits lung cancer cell proliferation, migration, and invasion by inhibiting the activity of the Wnt/β-catenin signaling pathway.
    Lin H; Shangguan Z; Zhu M; Bao L; Zhang Q; Pan S
    J Cell Biochem; 2019 Jun; 120(6):10625-10632. PubMed ID: 30697812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of lncRNA SLC16A1-AS1 Suppresses the Growth and Metastasis of Breast Cancer
    Jiang B; Xia J; Zhou X
    Front Oncol; 2022; 12():712475. PubMed ID: 35372039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA SLC16A1-AS1 is Upregulated in Glioblastoma and Promotes Cancer Cell Proliferation by Regulating miR-149 Methylation.
    Long Y; Li H; Jin Z; Zhang X
    Cancer Manag Res; 2021; 13():1215-1223. PubMed ID: 33603467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA NCK1-AS1 promotes the tumorigenesis of glioma through sponging microRNA-138-2-3p and activating the TRIM24/Wnt/β-catenin axis.
    Huang L; Li X; Ye H; Liu Y; Liang X; Yang C; Hua L; Yan Z; Zhang X
    J Exp Clin Cancer Res; 2020 Apr; 39(1):63. PubMed ID: 32293515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IGFL2-AS1 facilitates tongue squamous cell carcinoma progression via Wnt/β-catenin signaling pathway.
    Zhao R; Wang S; Tan L; Li H; Liu J; Zhang S
    Oral Dis; 2023 Mar; 29(2):469-482. PubMed ID: 34085359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. lncRNA SLC16A1-AS1 as a novel prognostic biomarker in non-small cell lung cancer.
    Liu HY; Lu SR; Guo ZH; Zhang ZS; Ye X; Du Q; Li H; Wu Q; Yu B; Zhai Q; Liu JL
    J Investig Med; 2020 Jan; 68(1):52-59. PubMed ID: 31371390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SH3PXD2A-AS1/miR-330-5p/UBA2 ceRNA network mediates the progression of colorectal cancer through regulating the activity of the Wnt/β-catenin signaling pathway.
    Guo S; Zhu KX; Yu WH; Wang T; Li S; Wang YX; Zhang CC; Guo JQ
    Environ Toxicol; 2021 Oct; 36(10):1969-1980. PubMed ID: 33073888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA SLC16A1-AS1 contributes to the progression of hepatocellular carcinoma cells by modulating miR-411/MITD1 axis.
    Duan C
    J Clin Lab Anal; 2022 Apr; 36(4):e24344. PubMed ID: 35293026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silence of FAM83H-AS1 promotes chemosensitivity of gastric cancer through Wnt/β-catenin signaling pathway.
    Wang B; Guan G; Zhao D
    Biomed Pharmacother; 2020 May; 125():109961. PubMed ID: 32028241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.